The onset of feeding at birth is a vital step for the adaptation of the neonate to extra-uterine life. Prader-Willi syndrome (PWS) is a complex neurogenetic disorder caused by the alteration of several imprinted contiguous genes including MAGEL2. PWS presents with various clinical manifestations, including poor suckling behaviour and feeding problems in neonates. Hypothalamic defects have been proposed but the pathophysiological mechanisms remain poorly understood. Here we report that a Magel2 deficient mouse with 50% neonatal mortality had an altered onset of suckling activity and subsequent impaired feeding, suggesting a role of MAGEL2 in the suckling deficit seen in PW newborns. The hypothalamus of Magel2 mutant neonates showed a significant reduction of oxytocin.
INTRODUCTION
After delivery, adaptation to extra-uterine life involves a set up of several vital processes including oral feeding. The transition is abrupt and needs swift appropriate behaviour. The mechanisms which trigger the onset of feeding at birth are still poorly understood.
Prader-Willi syndrome is a rare genetic disease (PWS; OMIM 176270) with a complex and progressive phenotype (1) including feeding problems from birth. PWS is viewed as having two identifiable phases in the feeding behaviour. During phase I of the syndrome, failure to thrive, feeding difficulties and slow weight gain as well as impaired growth are the most striking symptoms; newborns have poor muscle tone and the suckling activity is weak or absent. Tube feeding is often required in the first weeks of life and babies show little interest in feeding during the first few months of their lives. Paradoxically, during phase II (after 2 years approximately), an insatiable appetite takes over and children often demonstrate voracious food seeking behaviour (2) . To date, much of the PWS phenotype is consistent with a hypothalamic dysfunction (3) but the pathophysiological mechanism is not yet completely identified. Noticeably, in some adult PW patients a reduction in the number of oxytocin-expressing neurons in the paraventricular (PVN) region (4) has been reported and an abnormally low level of circulating oxytocin (5) .
reported, only one patient had a reported significant hypotonia and weak suckling from birth requiring tube feeding (8) . Consequently, a major role of the SNORD116 locus in the PWS phenotype is now supported. However, the question about the mechanism(s) by which these deletions, including the SNORD116 locus, cause the physiopathology observed in these patients remains open. Effectively, it might be through the functional role of SNORD116 SnoRNAs, which is poorly understood, and/or it might also involve an impairment of the expression of the other PWS candidate genes in the brain of these patients, PWS genes being highly expressed in the brain. The data available in the literature are not sufficient to discriminate these two alternatives.
Several murine models have been generated resulting in an absence of expression of all the paternally-expressed genes; they recapitulate the early failure to thrive and show perinatal lethality but none of surviving mice showed obesity (see for review (9) ). Targeted mutations of specific genes (such as Necdin, Snord116) have been created and, depending on genetic background and on the level of investigation of these models, the phenotypes recall some of the PW features. For instance a role for NECDIN in PWS breathing deficits is strongly suggested (10, 11) . Two mouse models with a deletion of the Snord116 gene cluster have been reported (12, 13) . Both models result in postnatal growth retardation suggesting a role of SNORD116 RNAs in the failure to thrive observed in PW infants. One model was further investigated showing hyperphagia but no obesity, delayed sexual maturation, increased anxiety, defect in motor learning (13) . One of the candidate genes in this region, MAGEL2, belongs to the family of MAGE (Melanoma Antigen Gene Expression) genes (14, 15) , the function of which is still elusive. In the mouse adult brain, Magel2 transcripts are expressed in several structures and in the hypothalamic nuclei a strong and circadian expression was detected (Allan brain Atlas, http://www.brain-map.org; http://expession.gnf.org; (16, 17) ).
Magel2 is also strongly expressed in the mouse developing nervous system (18, 19) . Previously, a mouse model for Magel2-deficiency has been created. Adult Magel2 deficient mice showed circadian dysfunction and reduced motor activity, impaired reproductive function, altered metabolism resulting in increased adiposity after weaning and behavioural problems (17, 20, 21, 22) . A postnatal lethality (around 10%) is observed (17) and neonatal growth retardation due to a reduced gain weight observed from birth until weaning (20) has also been described but the cause(s) has not been further investigated.
Here we describe a new mouse mutant deficient for Magel2 recalling the suckling deficit of human PW newborns and suggesting that Magel2 plays a role in the failure to thrive described in PWS. The present study reflects the vital importance of feeding onset in neonates and provides evidence for a pivotal role of Magel2 in this behaviour. Magel2 deficiency correlated with a significant hypothalamic decrease of oxytocin (OT). The use of a specific OT-receptor antagonist in wild type animals and oxytocin rescue experiments in Magel2 KO neonates demonstrated a relationship between oxytocin deficiency and poor feeding behaviour at birth. Importantly, our results lead us to propose a therapeutic treatment for the suckling deficit of PW neonates by external supply of oxytocin. 
RESULTS

Neonatal death of Magel2 deficient mice
Gene targeting was used to generate Magel2-null mice on 129Sv/Pas genetic background ( Fig.1 and Supplementary data). Since Magel2 is an imprinted gene with a paternal expression only, mice with a paternally deleted Magel2 allele (m+/p-) are thereafter referred as Magel2 KO mice since they are functionally equivalent to Magel2 null mice. Indeed Magel2 transcripts were not detected in Magel2 KO embryos ( Fig.1d ), compared with wild type individuals from the same litter.
Magel2 KO mice were significantly under represented at weaning time (Supplementary   Table1) . This under-representation was dependent on the genetic background, with a 51.4% lack of Magel2 KO mice after 5 to 7 backcrosses on C57Bl6/J genetic background (Table1b).
In the surviving mutants, males and females were equally represented.
During embryogenesis (from E10.5 to E18.5) and in early neonates (2-4 hours old), 50% of Magel2 deficient mice were observed, as expected in a Mendelian ratio (Supplementary Table   2 ). However, genotyping of litters at P1, revealed that only 58% of Magel2 KO mutants versus 99% of wild type (Supplementary Table 2 ) were alive whereas 42% of Magel2 KO mutants versus 1% of wild type (WT: n=1, KO: n=32; CHI 2 test, P<0.001) died by the end of P1 (carcasses being present in the box). All the studies reported thereafter were done on mutant or wild type pups after 7 backcrosses on a C57Bl6/J genetic background (over 98%). 7 neonates beat normally. All organs were present in the KO neonates and looked similar to those of wild type littermates as confirmed by histological analyses ( Supplementary Fig.1 ). In parallel, we followed the growth of surviving mutants compared to wild type newborns.
First, between P0 and P3, we observed a 43% significant reduction in the weight gain of obesity was not developed in adulthood.
Taken together, these data suggest that in the absence of Magel2, the initiation of feeding process after birth is altered, leading to an early death of approximately 50% of mutants.
Feeding behaviour in Magel2 KO pups: the onset of suckling activity is disturbed.
One crucial step to survive is to find food. Indeed, mouse neonates have to find their mother's nipples and suckle by themselves. This step involves: an awakened state, an olfactory or tactile functional system to locate the mother's nipples, a rooting reflex, a rhythmic suckling reflex and swallowing (23) . Thus, several sensory and motor systems involving different brain structures and muscles are implicated (24) .
Soon after birth, Magel2 KO pups did not appear hypotonic and reacted with similar movements as observed in controls, notably when they are placed on their back. During the first postnatal day, control and mutant pups exhibited a similar rooting reflex (Supplementary methods). Furthermore Magel2 KO newborns could open and close their mouth normally. All these observations are in agreement with a normal motor activity necessary for suckling in Magel2 mutants. Importantly, all mutant newborns are together with their littermates, close to the mother at least during the 12 first hours and later for surviving animals, suggesting that separation and lack of mother care is not involved in the phenotype of mutant newborns.
Then, we performed a suckling test, recording the attachment of the newborn to the mother's nipple (25) . We observed a significant difference in suckling activity (WMW test, P<0.005) between wild type (n=43) and Magel2 KO (n=31) newborns issued from 10 litters ( Table 1) :
39% of Magel2 mutant versus 2% of wild type animals had no suckling activity, 39% of Magel2 mutant versus 21% of wild type animals had a weak suckling activity and only 22%
of Magel2 mutant versus 77% of wild type animals have a strong activity. Altogether, these data suggested that at birth Magel2 KO mice had defects in the initiation of suckling stimulation leading to impaired feeding and death of ≈ 50% of newborns. The remaining mutant neonates were able to initiate the suckling process and to survive.
Neuroendocrine function during the early postnatal period in Magel2 KO
Magel2 is strongly expressed in the hypothalamus that is crucial for feeding control.
Moreover hypothalamic dysfunction is suspected in the pathophysiology of PWS (for review (3) ). There was an absence of obvious structural modifications in brain anatomy and particularly in the hypothalamus of mutant newborns (Supplementary data and Fig.2 ). This result did not exclude a functional alteration. The production of neuropeptides and hormones might be modified, in particular those which are known to play an important role at birth.
Circulating glucocorticoids play an important role in the adaptation of the neonate to the extra uterine life (26, 27) , in particular in the regulation of energy homeostasis (28) . Just after birth, a sex independent abrupt rise in plasma AdrenoCorticoTropin Hormone (ACTH) (10 min after birth) has been previously described, followed by an increase in plasma and adrenal corticosterone levels (one hour after birth) (26) . This de novo synthesis might be involved in the initiation of primitive reflexes. We then used enzyme immunoassay (EIA) tests and compared the level of plasma ACTH, in caesarean-section newborns from pregnant females at term (E18.5); we did not observe any significant difference in the ACTH plasma level between Magel2 KO and wild type mice issued from three litters (WT: 5.4 ng/ml (4.6, 5.8), n= 9; KO: 5.9 ng/ml (5.4, 6.1), n=11; WMW test, N.S.). Using EIA, we also quantified and compared the level of plasma corticosterone, 60 min after birth. There was no significant difference between both genotypes, male newborns being issued from 5 litters (WT: 750 ng/ml (650, 1050), n= 10; KO: 575 ng/ml (425, 750), n=10; WMW test, N.S.).
Several hypothalamic neuropeptides such as Oxytocin (OT) (29), Arginine-Vasopressin (AVP) (30, 31, 32) , and Orexin-A (OXA) (33) are also thought to play an important role during the early postnatal period, however their role in onset of feeding at birth is not clear. Using an EIA approach, the quantity of these mature neuropeptides produced in the hypothalamus and in the hypophysis of Magel2 mutant neonates and their wild type littermates was measured.
In the hypothalamus, we observed an average 36% reduction of mature OT, a 22% reduction of mature OXA and a 20% reduction of mature AVP ( (Table 2 ). In the pituitary gland, the quantity of OT, AVP and ACTH was not significantly different between both genotypes ( Table 2 ). In conclusion, the deficiency in Magel2 expression led to an impairment of hypothalamic production of at least several mature amidated neuropeptides (OT, AVP, OXA), the production of OT being the most affected.
Immunohistochemical analyses of hypothalamic neurons producing OT, AVP and OXA.
The hypothalamic neurons expressing these peptides (OT, AVP, OXA) were studied by immunohistochemistry. Stronger OT immunolabelling was observed, 3-5 hours after birth, in the PVN of mutant compared to wild type animals (3 mice per group), using a first antibody against OT that did not discriminate between the different OT forms produced in its maturation process. This observation did not seem consistent with the 36% decrease in OT mature form seen in Magel2 KO hypothalamus by EIA (see above), but might be explained by an accumulation of not fully processed OT forms. In order to discriminate which forms might be accumulated, we then used two antibodies allowing us to specifically stain for 1)
OT-associated neurophysin (PS-38) detecting the respective OT prohormone and 2) for the OT-peptide intermediates (VA-10) (34, 35, 36) . Using co-immunolabelling ( Fig Similarly to this study, we performed a co-immunolabelling on PVN sections using antibodies specifically raised against the AVP-associated neurophysin (PS-41) and the AVP-peptide intermediates (VA4) (34, 35, 36) . A confocal analysis ( Fig.2b) Finally, we also used an antibody that recognizes specifically the prepro-orexin, the initial unprocessed form of OXA. We observed a similar immunolabelling and we counted the same number of prepro-orexin-expressing neurons in the lateral hypothalamus of mutant (258 (253, 269), n=5) and wild type (264 (235, 266), n=5) animals analysed at P0 (data not shown).
In conclusion, these results revealed a specific accumulation of OT intermediate forms in
Magel2 KO compared to wild type neonates hypothalami although the OT-prohormone is similarly expressed. One interpretation is that the transformation of OT intermediate forms to amidated OT is impaired in Magel2 KO hypothalami in neonates, leading to an accumulation of these intermediate forms and to a reduced quantity of mature amidated OT. Noticeably, the fully processed amidated form of OT is detected one day before birth and increases abruptly after birth (35, 36) . Thus, another interpretation is that the maturation of OT neurons is delayed in mutant hypothalami leading to an accumulation of OT intermediate forms, hence an impairment in the release of mature OT, normally observed at birth.
Injection of an oxytocin receptor antagonist prevents feeding in wild type neonates and induces postnatal lethality
Altogether, the previous data, suggested that OT deficiency might participate in the Magel2 KO feeding phenotype at birth. To validate this hypothesis, the SSR 126768A compound, a specific OT antagonist (OTA) that displays even higher affinity (6 fold increase) for the OT receptor than natural OT and a low affinity for AVP-receptors (37) , was used in wild type animals. We proceeded to a single injection of 3µg (20µl) (37) in 68 wild-type C57Bl6/J newborns (9 litters), 1 to 1.5 hour after birth. In parallel, in the same conditions, we injected the vehicle (20µl) in 48 wild-type C57Bl6/J newborns (7 litters Thus, the SSR 126768A OTA at a dose of 3µg appeared to have a specific effect, preventing the feeding process and leading to death, only when it was injected in a specific window of time after birth, before the suckling activity was initiated. This phenotype simulated the Magel2 KO feeding phenotype at birth.
The suckling initiation deficit phenotype and the lethality resulting from a lack of
Magel2 can be rescued by injection of oxytocin
The results obtained with the injection of SSR 126768A OTA allowed us to hypothesize that we might restore a normal feeding behaviour in Magel2 KO newborns with an OT injection just after birth. Early neonatal manipulation of OT was reported in the literature without alterations of the postnatal development (38, 39, 40) . We then decided to inject 2µg of OT in
Magel2 KO and wild type newborns, 3 to 5 hours after birth, the time when wild type newborns started to suckle but not the mutant neonates. In a first step, using two cohorts of wild type pups (n=28), we checked that a subcutaneous (s.c.) injection of isotonic saline (20µl NaCl 0.9%) and a s.c. injection of oxytocin (2µg in 20µl of NaCl 0.9%) solution did not induce a specific lethality. In a second step, thirteen litters including a total of 49 Similar experiments were performed with AVP injections (Supplementary data) but whatever the dose injected, AVP did not rescue the phenotype of Magel2 deficient neonates.
We conclude that one single injection of OT, in a specific window of time, 3-5 hours after birth, was able to efficiently rescue the death rate due to the feeding deficit observed in
Magel2 KO newborns.
DISCUSSION
The mechanisms that trigger the onset of feeding at birth are complex and multifactorial. The cause of feeding problems encountered in PW newborns is often viewed as a consequence of the underlying hypotonia that in turn would result in poor suckling, but this has not been proven and alternative explanations are possible. The inability to suckle properly is also met with a lack of interest in food and/or avoidance behaviour. Here, we show that the Magel2 KO neonates, while not hypotonic, are unable to feed, as a consequence of their inability to search food and to suckle properly. This study demonstrates for the first time a role of Magel2 in the onset of feeding. Magel2 KO mouse is the only model, with the abrogation of one specific gene among all PW candidate genes leading to a deficit in suckling initiation. We propose that the lack of MAGEL2 contributes to the suckling deficit and, consequently, to the failure to thrive observed in PW infants (see for review (41, 42) ). In this line, it is noticeable that a mouse model in which Mkrn3, Necdin, Magel2 (43) showed no expression, is associated with neonatal lethality (depending on the content of C57BL/6J genetic background) suggestive of a failure to thrive although mice lacking the paternal expression of Mkrn3 (44) or Necdin do not present a failure to thrive at birth. Furthermore, one patient with a deletion including MKRN3, MAGEL2 and NECDIN (45) had no PWS but some symptoms with feeding problems during her first 18 months of life.
The failure to thrive described in PWS is probably caused by a complex mechanism involving at least two genes, MAGEL2 and SNORD116 gene cluster. Effectively, human genetic studies . In addition, both Snord116 knock-out mouse models showed a growth deficiency. Apparently, this growth deficiency does not result from a deficit of the suckling initiation (as in Magel2 KO neonates) because, firstly, the phenotype appears at P2 (13) or P5 (12) but not from birth and, secondly, the presence of milk was detected in the stomach of P5 neonates (13) . Furthermore, Ding et al. (42) showed that the gene expression profiles of Snord116 deletion mice and wild-type littermates were very similar at all time points and conditions, arguing against a role of Snord116 in feeding regulation in the neonatal period.
Tacking in account all these data, we conclude that SNORD116 gene cluster and MAGEL2
might contribute together to the failure to thrive observed in PWS. But, in this process, a different role might be attributed to each locus: MAGEL2 being an actor of the suckling initiation and SNORD116 locus playing a role in the postnatal growth, with a yet unidentified mechanism.
The rescue of the present Magel2 KO phenotype via oxytocin injection has potentially important consequences and applications in the therapy/management of PW newborns. The forced, long-lasting and invasive feeding procedure required in PW infants might be alleviated by a unique oxytocin supply, which would trigger normal feeding onset at birth and subsequent maintenance of feeding behaviour.
In the previous reported Magel2 KO mouse model, a postnatal lethality (10%) (17) and a neonatal growth retardation (20) have been reported but not further studied. Thus, a similar deficit in the feeding behaviour might exist in this Magel2 KO strain but has not been described because it has not been further investigated. Necdin KO mouse models (46, 47) but the cause of death was the same, a breathing deficiency (48) . Finally, a difference in the KO molecular strategy is noticeable since the promoter has been deleted in our KO mouse model but it has been kept in the previous model to allow the expression of LacZ gene. The presence or absence of the promoter might change the severity of the phenotype by modifying the expression of proximal genes that would share regulatory elements or by modifying the expression of other genes from the MAGE gene family that have identical regulatory sequences.
The role of hypothalamic circuits and of different neuropeptides in controlling food intake, body weight and glucose homeostasis is crucial and well documented in mature mammals (49) as in the postnatal period (50, 51) . However, the role of the hypothalamus in the on set of oral feeding at birth has been barely investigated. In Magel2 mutant pups, the organization of to date, the mechanism underlying this deficiency of amidated OT production and its link with observed a significant reduction (20%) of AVP and OXA production. Immunohistochemistry analysis did not reveal an accumulation of intermediate AVP forms as we observed for OT.
However, the number of cells expressing the AVP prohormone (NP-AVP) and intermediate AVP forms in the PVN being similar in mutant and wild type, we cannot exclude that an impairment in prohormone processing does also exist for AVP leading to a 20% decrease of production of mature forms. Interestingly, previous studies on five post-mortem adult PWS brains using IHC (52, 53) suggest a processing defect in AVP production in PW patients.
Similarly, the number of cells expressing OXA prohormone (prepro-orexin, data not shown)
in the lateral hypothalamus is the same between mutant and wild type pups although a reduced OXA quantity is detected in Magel2 KO animals. In this line, Kozlov and his colleagues have suggested that, in adult hypothalamus of their Magel2 KO mouse model, the maturation process of prepro-orexin was altered (17) .
Whatever the mechanism involved, we show here that Magel2 plays a crucial role in the onset of feeding at birth. We also showed that the OT/OT receptor system might be a major stimulus for the newborn to initiate milk intake. Interestingly, the injection of a specific antagonist of the oxytocin receptor (SSR 126768A) in wild type newborns after they had already ingested milk, had no more effect on survival and on feeding behaviour in the following days, as opposed with the effects of such an injection before feeding onset. Thus, this study reveals an as-yet unknown and unexpected role of OT in the initiation of feeding behaviour, in a specific time-window just after birth. Does this mean that oxytocin, produced by the newborn, is a factor necessary to trigger the onset of feeding? Noticeably, in rats, the fully processed amidated form of OT is detected one day before birth and increases abruptly after birth (35, 36) although its function at this time is not known. Furthermore, a study on rabbit pups (54) reported that the oxytocinergic system of the supra optic nucleus and PVN is differentially activated in pups by suckling of milk or by anogenital stroking, a sensory stimulation triggering suckling activity. These data support a role of OT, at birth, in stimulating the search of food and/or in initiating the suckling activity. Surprisingly, the mice knock-out for the gene encoding OT are viable and no feeding problem has been reported at birth (55, 56, 57) . In those animals, alternative pathways may be called in action and substitute for the fully defective OT production. For instance the endocannabinoid-cannabinoid receptor system has also been shown to play a role in the initiation of the milk suckling process during the first days postnatally in the mouse (58) . In contrast, Magel2 KO mice have 'less effective only' OT system than wild-type animals and have also a significant reduction of hypothalamic OXA and AVP; for still unexplained reason, such or other alternative pathways might be operating in only the approximately 50% of Magel2 mutants that are able to feed and survive.
In conclusion, the present study provides the first evidence for a key role played by Magel2
and by the OT/OTR system in the initiation/stimulation of feeding behaviour at birth. These results open a novel therapeutic strategic option in the impairment of onset feeding behaviour observed in PW newborns. Moreover, feeding is often disturbed in babies with various genetic syndromes and in infants presenting with an inability to ingest food and known as "non-organic failure to thrive" syndrome (2) . Administration of OT might be a safe and powerful therapeutic agent not only in PWS but generally to stimulate the feeding behaviour and milk ingestion in those various feeding disorders with early onset.
MATERIALS AND METHODS
Ethics statement
All breedings and experiments were carried out in keeping with the European guidelines for the care and use of laboratory animals (Council Directive 86/6009/EEC).
Mouse Magel2 KO line generation
Two fragments containing genomic sequences 5′ and 3′ to the Magel2 region to be deleted 
Neonates suckling behaviour
This test was performed as previously described (25) . Briefly, 2-6 h after delivering their newborns, females were anesthetized with 0.1% Rompun Xylasine / 10mg/ml Ketamine Imalgene (0.1ml /10g of tissue) and laid down on their back, on a heated surgical pad (37°C).
Newborns were individually tested for their capacity to find and grab to one of their mother's nipple and to suck milk efficiently. Scores are described in Table1.
In situ hybridization and Immunohistochemistry
Tissues from whole embryos (E12.5) or P0 brains were dissected, fixed and treated as previously described (47, 59) . 14 µm sagittal or coronal frozen sections were collected. For
Magel2 in situ hybridization (ISH) analyses, sections were treated and hybridized with a
Magel2 antisens digoxigenin-labeled riboprobe (nucleotides 3366-4053; XM_622091), at 70°C in 50% formamide, as described previously (59) . For double Magel2 and Necdin ISH analyses, sections were hybridized with Magel2 antisens digoxigenin and Necdin (nucleotides 2130-2420; D76440) fluorescein-labeled riboprobes (18) . Immunohistochemistryon cryosections was performed as previously described (18) . A polyclonal rabbit anti-Necdin Tramu (47)). Then, we performed co-immunolabelling using a mouse monoclonal antibody highly specific against the mouse neurophysin associated to OT(PS38) and a polyclonal antibody which recognizes the intermediate forms of OT(VA10) (34, 35) . For vasopressin, we performed co-immunolabelling using a mouse monoclonal antibody highly specific against the mouse neurophysin associated to AVP(PS41) and a polyclonal antibody which recognizes the intermediate forms of AVP (VA4) (34, 35) . PS38, PS41, VA10 and VA4 are a gift from
Counting oxytocin, vasopressin and prepro-orexin neurons in P0 brains
Pr. H. Gainer.
For prepro-orexin neuron counting, P0 brains were treated as described in 
Enzymes-linked immunoassay analyses
Enzyme-linked immunoassays analyses were performed to quantify levels of neuropeptides in P0 hypothalamus and hypophyses. P0 hypothalamus and hypophyses were dissected from 10:00 to 12:00 am (delivery occurring in early morning), before post-natal death affecting a proportion of Magel2-KO neonates occurred (mostly from 12:00 hours after birth to P1).
Tissues were sonicated in a protease inhibitor cocktail (Complete Mini, Roche), incubated at 
Injection of Oxytocin and Vasopressin
Three to 5 hours after delivery, wild type pups or pups issued from a cross between an heterozygote (+/-) male with wild type females were temporally removed (10 min) from their mother, weighted and given a single s.c. (in the ventral region at the level of floating ribs) injection (20µl) of isotonic saline or 2µg oxytocin (Phoenix Pharmaceuticals. Inc., Catalog
No.051-01) dissolved in isotonic saline (20µl). This dose of OT was used because there is a literature indicating that during the neonatal period these doses are not toxic but can affect a variety of physiological responses in male and female rats and prairie voles as well as neuronal activation in neonates (38, 39) . Following the same protocol, we injected vasopressin (Phoenix Pharmaceuticals. Inc., Catalog No.065-07) at different doses. At P2, pups were scarified to be genotyped.
Injection of SSR126768A
A first cohort of C57Bl6 wild type newborns were removed from their mothers 1-1h30 after their birth and very rapidly were given a single s.c. injection (20µl) of vehicle control ( 0.2% ethanol in distilled water) or 3 µg (in 20µl of 0.2% ethanol in distilled water) of SSR126768A (OTA). A first cohort of C57Bl6 wild type newborns were injected 12-24 hours after birth. The dose of OTA used was based on previous publications (37) .
We chose to use the Oxytocin antagonist SSR126768A (a gift from C. Serradeil-Le Gal, Sanofi-Synthélabo Recherche, Toulouse, France) because it was already well characterized. It was shown to have a high affinity for OTR in different species, including mouse, and a high selectivity for OTR with weak affinity for AVP receptors (37) . It has been used at 1, 3 or 10 µg/g in rats (37) without inducing lethality or any strong secondary effect. Furthermore, at least on uterus, SSR126768A showed a rapid onset of action and a long duration effect (24h hours after administration with a dose as low as 3µg/g) (37) . Then, we chose to use it at 3 µg/g in our experiments.
Statistical analyses
Taking into account the size of the sample and the normality or absence of normality of the distribution of the different values, we used appropriate statistical tools. Nonparametric statistical tools (Sigmastat software) or exact statistical tools (StatXact software) were used depending on the size of the sample (n). All tests are two-tailed tests. In the results, values are indicated as following: (Q2 (Q1, Q3), n, P value) where Q2 is the median, Q1 is the first quartile and Q3 is the second quartile. Wilcoxon-Mann-Whitney test is refered as WMW in the text. The level of significance was set at a P-value less than 0.05. Table 1: Suckling test Suckling activity is considered as: a) absent if there is no attachment to the nipple (scored 0), b) weak if the latency for attachment is over 3 min and suckling activity itself is null or weak and not maintained (scored 1), or c) strong if the latency for attachment is less than 3 min and suckling activity itself is strong (scored 2). *Pups tested are issued from three litters, about 2-3 hours old. Pups had no milk in their stomach before the test. There is a significant difference in the activity of mutants and controls (Wilcoxon-Mann-Whitney test, P<0.005). ° Pups tested are issued from seven litters, between 4 to 8 hours old. Majority of wild type mice had milk in their stomach but mutant had an empty stomach. There is a significant difference in the activity of mutants and controls (Wilcoxon-Mann-Whitney test, P<0.5e-004). Results from Elisa tests in order to compare, between mutant and wild type newborns (at P0), the quantity of several neuropeptides produce in hypothalamus or pituitary gland. Values are indicated as: Median(Quartile1, Quartile3).
Tables
Suckling activity
